Title of article :
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
Author/Authors :
Timo Vesikari، نويسنده , , A Karvonen، نويسنده , , Roman Prymula، نويسنده , , V Schuster، نويسنده , , JC Tejedor، نويسنده , , R Cohen، نويسنده , , F Meurice، نويسنده , , HH Han، نويسنده , , S Damaso، نويسنده , , A Bouckenooghe، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
7
From page :
1757
To page :
1763
Abstract :
Background We aimed to assess the efficacy of the oral live attenuated human rotavirus vaccine Rotarix (RIX4414) for prevention of rotavirus gastroenteritis in European infants during their first 2 years of life. Methods 3994 study participants were enrol
Journal title :
The Lancet
Serial Year :
2008
Journal title :
The Lancet
Record number :
592158
Link To Document :
بازگشت